0000899243-19-025300.txt : 20191008 0000899243-19-025300.hdr.sgml : 20191008 20191008160804 ACCESSION NUMBER: 0000899243-19-025300 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191007 FILED AS OF DATE: 20191008 DATE AS OF CHANGE: 20191008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shepard Jay CENTRAL INDEX KEY: 0001587788 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36361 FILM NUMBER: 191142808 MAIL ADDRESS: STREET 1: 15977 GRANDVIEW AVENUE CITY: MONTE SERENO STATE: CA ZIP: 95030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aravive, Inc. CENTRAL INDEX KEY: 0001513818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264106690 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LYONDELLBASELL TOWER STREET 2: 1221 MCKINNEY STREET, SUITE 3200 CITY: HOUSTON STATE: TX ZIP: 77010 BUSINESS PHONE: 936-355-1910 MAIL ADDRESS: STREET 1: LYONDELLBASELL TOWER STREET 2: 1221 MCKINNEY STREET, SUITE 3200 CITY: HOUSTON STATE: TX ZIP: 77010 FORMER COMPANY: FORMER CONFORMED NAME: Versartis, Inc. DATE OF NAME CHANGE: 20110223 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-07 0 0001513818 Aravive, Inc. ARAV 0001587788 Shepard Jay C/O ARAVIVE, INC., 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 1 1 0 0 President and CEO Common Stock 2019-10-07 4 S 0 4004 6.817 D 72754 D Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units, which were previously reported in Table I following the date of grant. /s/ Abel Svitavsky, Attorney-in-fact 2019-10-08